Get monthly insights on Clinical Research new innovations straight in your mail box.
News & Events
Breast cancer, a disease that affects millions of women and men worldwide, has been a focal point of medical research for decades. Thanks to relentless efforts from scientists, doctors, and advocates, significant progress has been made in understanding, diagnosing, and treating breast cancer. In this blog post, we’ll explore recent advancements in breast cancer research and the promising future treatments that offer hope to those affected by this disease.
The Current Landscape of Breast Cancer Research
Breast cancer remains one of the most common cancers globally. However, there’s reason for optimism. Over the years, advancements in technology and breast cancer research have led to earlier detection, improved treatment options, and better overall outcomes for patients.
Early Detection and Screening
One of the most critical aspects of breast cancer management is early detection. Mammography, a standard screening tool, has undergone refinements that enhance its accuracy. Additionally, researchers have explored new techniques such as 3D mammography and digital breast tomosynthesis to provide clearer images, improving the chances of identifying cancer at its earliest stages.
Personalized Treatment
Breast cancer is not a one-size-fits-all disease. Recent developments in genomic testing have allowed doctors to tailor treatment plans to an individual’s specific cancer subtype. This precision medicine approach minimizes side effects and increases the effectiveness of treatment, offering a more personalized and hopeful outlook for patients.
Immunotherapy
Immunotherapy has revolutionized cancer treatment, and breast cancer is no exception. Immune checkpoint inhibitors, such as pembrolizumab and atezolizumab, have shown promise in clinical trials, offering new options for patients with certain types of breast cancer. These drugs work by blocking mechanisms that cancer cells use to evade the immune system, allowing the body to mount a stronger defence against the disease.
Recent Breakthroughs
Now, let’s delve into some recent breakthroughs that have sparked optimism in the breast cancer research community.
Liquid Biopsies
Researchers have made strides in developing liquid biopsies, a non-invasive method to detect cancer biomarkers in blood samples. Liquid biopsies can provide real-time information about the cancer’s progression and help determine the most effective treatment strategies, reducing the need for invasive procedures and offering patients a less burdensome experience.
Targeted Therapies
Advancements in understanding the molecular drivers of breast cancer have led to the development of targeted therapies. Drugs like Palbociclib, which inhibits proteins involved in cell division, have shown impressive results in clinical trials. These therapies aim to halt cancer’s growth by specifically targeting the pathways responsible for its development.
Artificial Intelligence (AI) and Machine Learning
AI and machine learning have made their mark in breast cancer research. These technologies can analyze vast amounts of medical data to identify patterns, assist in diagnosing breast cancer, and predict treatment outcomes more accurately. This not only saves time but also enhances the precision of medical decision-making.
The Promising Future
As we look ahead, the future of breast cancer research and treatment is filled with hope and possibilities.
Immunotherapy Advancements
Immunotherapy will continue to evolve, with ongoing research focusing on refining existing drugs and developing new ones. Combination therapies, which use multiple immunotherapies or combine immunotherapy with other treatments like chemotherapy, show promise for increasing response rates.
Gene Editing
Gene editing techniques like CRISPR-Cas9 offer exciting possibilities for tackling breast cancer at its genetic roots. Researchers are exploring ways to edit cancer-causing genes or enhance the body’s ability to fight off cancer cells, potentially leading to more effective […]
On 28 September 2021, Xcene Research took part in sensitizing and raising awareness for World Heart Day through a webinar tagged “Use Heart To Beat Cardiovascular Disease.” Here are excerpts from thought-provoking presentations delivered by two of our speakers.
Dr. Folasade Olugbemi-Paul
Hypertension is BP >140/90 mmHg measured on at least 2 different occasions. It affects up to 20% of the population of the world, and 46% of African adults, but only 1/3rd of affected people are aware, with only 2/3rd of them on treatment.
In most cases no cause may be found for a person’s high blood pressure, however, some factors can trigger or increase the risk of developing this condition. These include:
Having other medical conditions such as diabetes or high cholesterol levels may also increase risk. Some of these risk factors have been compounded by the COVID-19 pandemic which has resulted in many people becoming less active due to being quarantined or working from home.
Once diagnosed with hypertension, measures must be taken to reduce the severity of the condition and prevent complications. These measures include
A person with hypertension should also make sure to follow up and attend all clinic visits as scheduled and do all investigations recommended to screen for complications and prevent them.
To effectively manage hypertension both the patient and their clinician must work together to balance medical and non-medical interventions to reduce morbidity and mortality of this condition.
While hypertension is still a major killer, it can be tackled through preventive interventions, such as home blood pressure management. This is how we’re overcoming COVID-19 and this is how we’ll tackle heart diseases.
Dr. Osas Osunde
Cardiovascular disease is the leading cause of death worldwide with more than three quarters taking place in low and middle-income countries. Interventional strategies are focused on addressing behavioral risk factors such as tobacco use, unhealthy diet or lifestyle, obesity, physical inactivity, harmful or excessive alcohol use. The management of diabetes mellitus is having a direct impact on the prevention of cardiovascular diseases (CVD) as diabetes mellitus is a prime risk factor.
For more information, please contact pr@xceneresearch.com.
The Impact Africa Summit (IAS) a brainchild of Nigeria’s foremost contract research organization is designed to initiate strategic interactions and forge collaborations for excellence within the clinical research industry for Africa.
The goal of the Impact Africa Summit is to build a network of industry experts and stakeholders to help achieve sustainable capacity for pharmaceutical research and development in Africa. The inaugural edition, a Gala Night that would host international and local thought leaders would be held on 4th December 2020.
Due to the COVID-19 pandemic, this scaled-down version of the event will be leveraged to explore the way forward for clinical research and trials post-COVID-19. One of the event’s important features will be the presentation of excellence awards to industry experts whose novel ideas and concepts solved complex healthcare concerns before and during the pandemic.
We invite you to be a part of this high-level conference that would foster dialogue and exchange between the private and public health sectors by registering on the Impact Africa Summit website.